Compare iShares iBoxx $ High Yield Corporate Bond ETF (HYG) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares iBoxx $ High Yield Corporate Bond ETF vs Health Care Select Sector SPDR Fund — how do they compare? iShares iBoxx $ High Yield Corporate Bond ETF trades at $77.22 (market cap $17.89B), while Health Care Select Sector SPDR Fund trades at $170.79 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 2.4× iShares iBoxx $ High Yield Corporate Bond ETF's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, iShares iBoxx $ High Yield Corporate Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares iBoxx $ High Yield Corporate Bond ETF for 60 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| HYG | XLV | |
|---|---|---|
Market Cap | $17.89B | $43.48B |
Volume | 44,866,592 | 11,121,431 |
Sector | Fixed Income | — |
52-Week High | $81.28 | $175.68 |
52-Week Low | $76.90 | $141.95 |
Typical Hold Time | 60 Days | 100 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HYG trades at $77.23 with minimal daily movement (+0.06%), showing stability amid broader market volatility. The technical picture remains bearish with moving averages signaling continued downward pressure, though oscillators suggest potential stabilization. Recent dividend payments provide consistent income, with the latest $0.38 distribution paid in August 2026. The fund faces headwinds from rising Treasury yields and bond market volatility, with key technical indicators showing mixed signals between short-term stabilization and longer-term bearish momentum.
High yield bond ETFs like HYG face pressure from rising interest rates and inflation concerns, though the fund's diversified corporate bond portfolio offers yield advantages over Treasury securities. The current environment presents both income opportunities through attractive yields and risks from potential credit deterioration if economic conditions worsen. Investors should weigh the fund's income generation against interest rate sensitivity and credit risk exposure in the current tightening cycle.
XLV trades at $170.81, up 1.18% with a bearish technical signal from moving averages. The ETF's low 0.08% expense ratio and healthcare sector diversification provide defensive positioning amid market volatility. Recent options activity shows increased put volume, indicating some investor caution despite healthcare's traditional defensive characteristics during economic uncertainty.
Healthcare sector ETFs like XLV offer defensive exposure with potential upside from demographic trends and innovation. Key risks include political volatility around healthcare policy and concentration in large-cap US stocks. The ETF's cost efficiency and sector positioning make it attractive for long-term investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About iShares iBoxx $ High Yield Corporate Bond ETF
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
